Literature DB >> 22306404

Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Ronald Wetzel1.   

Abstract

Polyglutamine (polyQ) sequences of unknown normal function are present in a significant number of proteins, and their repeat expansion is associated with a number of genetic neurodegenerative diseases. PolyQ solution structure and properties are important not only because of the normal and abnormal biology associated with these sequences but also because they represent an interesting case of a biologically relevant homopolymer. As the common thread in expanded polyQ repeat diseases, it is important to understand the structure and properties of simple polyQ sequences. At the same time, experience has shown that sequences attached to polyQ, whether in artificial constructs or in disease proteins, can influence structure and properties. The two major contenders for the molecular source of the neurotoxicity implicit in polyQ expansion within disease proteins are a populated toxic conformation in the monomer ensemble and a toxic aggregated species. This review summarizes experimental and computational studies on the solution structure and aggregation properties of both simple and complex polyQ sequences, and their repeat-length dependence. As a representative of complex polyQ proteins, the behavior of huntingtin N-terminal fragments, such as exon-1, receives special attention.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306404      PMCID: PMC3362671          DOI: 10.1016/j.jmb.2012.01.030

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  185 in total

1.  Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening.

Authors:  Y Nagai; T Tucker; H Ren; D J Kenan; B S Henderson; J D Keene; W J Strittmatter; J R Burke
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.

Authors:  Dagmar E Ehrnhoefer; Martin Duennwald; Phoebe Markovic; Jennifer L Wacker; Sabine Engemann; Margaret Roark; Justin Legleiter; J Lawrence Marsh; Leslie M Thompson; Susan Lindquist; Paul J Muchowski; Erich E Wanker
Journal:  Hum Mol Genet       Date:  2006-08-07       Impact factor: 6.150

Review 3.  Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold.

Authors:  H L Paulson
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

Review 4.  Mutations and off-pathway aggregation of proteins.

Authors:  R Wetzel
Journal:  Trends Biotechnol       Date:  1994-05       Impact factor: 19.536

5.  The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.

Authors:  Erica Rockabrand; Natalia Slepko; Antonello Pantalone; Vidya N Nukala; Aleksey Kazantsev; J Lawrence Marsh; Patrick G Sullivan; Joan S Steffan; Stefano L Sensi; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

6.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

Authors:  C J Cummings; M A Mancini; B Antalffy; D B DeFranco; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

7.  Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length.

Authors:  K L Moulder; O Onodera; J R Burke; W J Strittmatter; E M Johnson
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

8.  Solid-state NMR study of amyloid nanocrystals and fibrils formed by the peptide GNNQQNY from yeast prion protein Sup35p.

Authors:  Patrick C A van der Wel; Józef R Lewandowski; Robert G Griffin
Journal:  J Am Chem Soc       Date:  2007-03-31       Impact factor: 15.419

Review 9.  Trinucleotide repeat DNA structures: dynamic mutations from dynamic DNA.

Authors:  C E Pearson; R R Sinden
Journal:  Curr Opin Struct Biol       Date:  1998-06       Impact factor: 6.809

10.  Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay.

Authors:  Lora Hamuro; Guangtao Zhang; Timothy J Tucker; Christopher Self; Warren J Strittmatter; James R Burke
Journal:  Assay Drug Dev Technol       Date:  2007-10       Impact factor: 1.738

View more
  86 in total

1.  Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1.

Authors:  Jennifer C Boatz; Talia Piretra; Alessia Lasorsa; Irina Matlahov; James F Conway; Patrick C A van der Wel
Journal:  J Mol Biol       Date:  2020-06-27       Impact factor: 5.469

2.  A solenoid design for assessing determinants of parallel β-sheet registration.

Authors:  Ellen M White; Andrew D Miranker
Journal:  Protein Eng Des Sel       Date:  2015-10-20       Impact factor: 1.650

3.  Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide.

Authors:  Christine C Lee; Mark C Julian; Kathryn E Tiller; Fanling Meng; Sarah E DuConge; Rehana Akter; Daniel P Raleigh; Peter M Tessier
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

4.  Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection.

Authors:  Bashkim Kokona; Carrie A May; Nicole R Cunningham; Lynn Richmond; F Jay Garcia; Julia C Durante; Kathleen M Ulrich; Christine M Roberts; Christopher D Link; Walter F Stafford; Thomas M Laue; Robert Fairman
Journal:  Protein Sci       Date:  2015-12-21       Impact factor: 6.725

5.  Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.

Authors:  Mingchen Chen; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

6.  Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR.

Authors:  Samuel A Kotler; Vitali Tugarinov; Thomas Schmidt; Alberto Ceccon; David S Libich; Rodolfo Ghirlando; Charles D Schwieters; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

Review 7.  Aggregation formation in the polyglutamine diseases: protection at a cost?

Authors:  Tiffany W Todd; Janghoo Lim
Journal:  Mol Cells       Date:  2013-06-19       Impact factor: 5.034

8.  Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex.

Authors:  Annika Scior; Alexander Buntru; Kristin Arnsburg; Anne Ast; Manuel Iburg; Katrin Juenemann; Maria Lucia Pigazzini; Barbara Mlody; Dmytro Puchkov; Josef Priller; Erich E Wanker; Alessandro Prigione; Janine Kirstein
Journal:  EMBO J       Date:  2017-12-06       Impact factor: 11.598

9.  Probing the Huntingtin 1-17 membrane anchor on a phospholipid bilayer by using all-atom simulations.

Authors:  Sébastien Côté; Vincent Binette; Evgeniy S Salnikov; Burkhard Bechinger; Normand Mousseau
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

10.  Free-Energy Landscape of the Amino-Terminal Fragment of Huntingtin in Aqueous Solution.

Authors:  Vincent Binette; Sébastien Côté; Normand Mousseau
Journal:  Biophys J       Date:  2016-03-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.